Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Head & Neck|February 16, 2024
Surgery for nonlocalizing hyperparathyroidism in high volume centerAustin B Miller, Ethan Frank, Alfred A Simental, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2020
Non-English language validation of patient-reported outcome measures in cancer clinical trialsStephen R Grant, Sonal S Noticewala, Walker Mainwaring, et al.The Oncologist|September 5, 2020
Professional Medical Writer Assistance in Oncology Clinical TrialsRamez Kouzy, Joseph Abi Jaoude, Walker Mainwaring, et al.BMC Cancer|June 13, 2021
Food and Drug Administration approvals in phase 3 Cancer clinical trialsJoseph Abi Jaoude, Ramez Kouzy, Marc Ghabach, et al.JNCI Cancer Spectrum|November 23, 2020
Racial and Ethnic Disparities Among Participants in US-Based Phase 3 Randomized Cancer Clinical TrialsStephen R Grant, Timothy A Lin, Austin B Miller, et al.Journal of the National Cancer Institute|June 6, 2019
The Trials (and Tribulations) of Complementary and Alternative Medicine in OncologyEthan B Ludmir, Amit Jethanandani, Walker Mainwaring, et al.Cancers|September 19, 2020
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical TrialsTimothy A Lin, Clifton David Fuller, Vivek Verma, et al.Mayo Clinic Proceedings|February 7, 2021
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled TrialsDario Pasalic, C David Fuller, Walker Mainwaring, et al.The Oncologist|April 10, 2020
Exclusion of Men from Randomized Phase III Breast Cancer Clinical TrialsKelsey L Corrigan, Walker Mainwaring, Austin B Miller, et al.JAMA Oncology|June 4, 2019
Factors Associated With Age Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, Walker Mainwaring, Timothy A Lin, et al.Pageof 2